Search research articles
Contact Us
Filters
Showing results (281-290 of 325) with videos related to
Page
of 33
Sort By:
Medical Care
|
February 25, 2015
The lifetime medical cost savings from preventing HIV in the United States
Bruce R Schackman, John A Fleishman, Amanda E Su, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 12, 2023
Daily Oral HIV Pre-exposure Prophylaxis Among Young Men Who Have Sex With Men in the United States: Cost-saving at Generic Drug Price
Alyssa K Amick, G Ege Eskibozkurt, Sybil G Hosek, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 15, 2024
Tuberculosis Preventive Treatment for Pregnant People With Human Immunodeficiency Virus in South Africa: A Modeling Analysis of Clinical Benefits and Risks
Linzy V Rosen, Acadia M Thielking, Caitlin M Dugdale, et al.
Plos One
|
December 25, 2013
Routine HIV screening in Portugal: clinical impact and cost-effectiveness
Yazdan Yazdanpanah, Julian Perelman, Madeline A DiLorenzo, et al.
BMJ Open
|
May 15, 2020
Novel microsimulation model of tobacco use behaviours and outcomes: calibration and validation in a US population
Krishna P Reddy, Alexander J B Bulteel, Douglas E Levy, et al.
Plos One
|
December 19, 2013
Validation and calibration of a computer simulation model of pediatric HIV infection
Andrea L Ciaranello, Bethany L Morris, Rochelle P Walensky, et al.
AIDS (London, England)
|
February 21, 2012
Genotype assays and third-line ART in resource-limited settings: a simulation and cost-effectiveness analysis of a planned clinical trial
Sarah B Lorenzana, Michael D Hughes, Beatriz Grinsztejn, et al.
Annals of Internal Medicine
|
January 31, 2022
Cost-Effectiveness of Long-Acting Injectable HIV Preexposure Prophylaxis in the United States : A Cost-Effectiveness Analysis
Anne M Neilan, Raphael J Landovitz, Mylinh H Le, et al.
The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine
|
December 24, 2017
The Optimal Age for Screening Adolescents and Young Adults Without Identified Risk Factors for HIV
Anne M Neilan, Richard Dunville, M Cheryl Bañez Ocfemia, et al.
The Lancet. Global Health
|
November 22, 2024
Cost-effectiveness of viral load testing for transitioning antiretroviral therapy-experienced children to dolutegravir in South Africa: a modelling analysis
Isaac Ravi Brenner, Clare F Flanagan, Martina Penazzato, et al.
Page
of 33
Search research articles
Search
Showing results (281-290 of 325) with videos related to
Sort By:
Page
of 33
Medical Care
|
February 25, 2015
The lifetime medical cost savings from preventing HIV in the United States
Bruce R Schackman, John A Fleishman, Amanda E Su, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 12, 2023
Daily Oral HIV Pre-exposure Prophylaxis Among Young Men Who Have Sex With Men in the United States: Cost-saving at Generic Drug Price
Alyssa K Amick, G Ege Eskibozkurt, Sybil G Hosek, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 15, 2024
Tuberculosis Preventive Treatment for Pregnant People With Human Immunodeficiency Virus in South Africa: A Modeling Analysis of Clinical Benefits and Risks
Linzy V Rosen, Acadia M Thielking, Caitlin M Dugdale, et al.
Plos One
|
December 25, 2013
Routine HIV screening in Portugal: clinical impact and cost-effectiveness
Yazdan Yazdanpanah, Julian Perelman, Madeline A DiLorenzo, et al.
BMJ Open
|
May 15, 2020
Novel microsimulation model of tobacco use behaviours and outcomes: calibration and validation in a US population
Krishna P Reddy, Alexander J B Bulteel, Douglas E Levy, et al.
Plos One
|
December 19, 2013
Validation and calibration of a computer simulation model of pediatric HIV infection
Andrea L Ciaranello, Bethany L Morris, Rochelle P Walensky, et al.
AIDS (London, England)
|
February 21, 2012
Genotype assays and third-line ART in resource-limited settings: a simulation and cost-effectiveness analysis of a planned clinical trial
Sarah B Lorenzana, Michael D Hughes, Beatriz Grinsztejn, et al.
Annals of Internal Medicine
|
January 31, 2022
Cost-Effectiveness of Long-Acting Injectable HIV Preexposure Prophylaxis in the United States : A Cost-Effectiveness Analysis
Anne M Neilan, Raphael J Landovitz, Mylinh H Le, et al.
The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine
|
December 24, 2017
The Optimal Age for Screening Adolescents and Young Adults Without Identified Risk Factors for HIV
Anne M Neilan, Richard Dunville, M Cheryl Bañez Ocfemia, et al.
The Lancet. Global Health
|
November 22, 2024
Cost-effectiveness of viral load testing for transitioning antiretroviral therapy-experienced children to dolutegravir in South Africa: a modelling analysis
Isaac Ravi Brenner, Clare F Flanagan, Martina Penazzato, et al.
Page
of 33